Antibiotics for Common Bacterial Infections
Urinary Tract Infections (Uncomplicated Cystitis)
For uncomplicated bacterial cystitis in adult women, prescribe nitrofurantoin 100 mg twice daily for 5 days as first-line therapy. 1
- Nitrofurantoin 5-day course is the preferred first-line agent, balancing efficacy with minimal antibiotic exposure and resistance development 1
- Alternative first-line options include fosfomycin 3g single dose or pivmecillinam 5-day course 2
- Trimethoprim-sulfamethoxazole (TMP-SMX) 160-800 mg twice daily for 3 days is second-line due to high resistance rates in many communities, but remains effective when local susceptibility is >80% 3, 2
- Fluoroquinolones (ciprofloxacin, levofloxacin) should be reserved for complicated infections or when other options are unsuitable due to resistance concerns 2
Common pitfall: Prescribing longer courses than necessary increases adverse effects without improving outcomes 1
Pyelonephritis (Complicated UTI)
- Ciprofloxacin 500-750 mg twice daily for 7 days when susceptibility is documented 3
- TMP-SMX 160-800 mg twice daily for 7 days is effective for susceptible E. coli strains 3
- For severe cases requiring hospitalization, initiate IV therapy with ceftriaxone 1-2g daily or fluoroquinolones, then transition to oral therapy based on culture results 2
Skin and Soft Tissue Infections (Cellulitis)
For nonpurulent cellulitis without MRSA risk factors, prescribe cephalexin 500 mg three times daily for 5-6 days. 3
Non-purulent cellulitis (streptococcal):
- Cephalexin 500 mg three times daily or cefazolin 1g IV every 8 hours for 5-6 days 3
- Penicillin VK 500 mg four times daily or benzylpenicillin IV are equally effective 3
- Clindamycin 300 mg three times daily for penicillin-allergic patients 3
MRSA-suspected cellulitis (purulent or risk factors present):
- Oral options: TMP-SMX 160-800 mg twice daily, doxycycline 100 mg twice daily, or linezolid 600 mg twice daily for 7-14 days 3
- IV options for severe infections: Vancomycin 15-20 mg/kg every 8-12 hours, daptomycin 10 mg/kg daily, or linezolid 600 mg twice daily 3
- Tedizolid 200 mg daily (6 days) is non-inferior to linezolid 10-day courses 3
Critical consideration: MRSA coverage is unnecessary for typical nonpurulent cellulitis unless specific risk factors exist (injection drug use, nasal MRSA colonization, penetrating trauma) 3
Respiratory Tract Infections
Community-Acquired Pneumonia:
- Amoxicillin 500-1000 mg three times daily for 5-7 days for outpatient pneumonia without comorbidities 3
- Add azithromycin 500 mg day 1, then 250 mg daily for 4 days if atypical coverage needed 3
- Levofloxacin 750 mg daily for 5 days as monotherapy alternative 3
Acute Sinusitis:
- Amoxicillin-clavulanate 875-125 mg twice daily for 5-7 days for bacterial sinusitis 3
- Doxycycline 100 mg twice daily or levofloxacin 750 mg daily for penicillin allergy 3
Acute Otitis Media:
- Amoxicillin 500-1000 mg twice daily for 5-7 days (children: 80-90 mg/kg/day divided) 3
- Amoxicillin-clavulanate for treatment failure or recent antibiotic exposure 3
Intra-Abdominal Infections
Mild to moderate community-acquired:
- Amoxicillin-clavulanate 875-125 mg twice daily 3
- Ciprofloxacin 500-750 mg twice daily plus metronidazole 500 mg three times daily 3
- Ceftriaxone 1-2g daily plus metronidazole 500 mg three times daily 3
Severe infections:
- Piperacillin-tazobactam 3.375g IV every 6 hours or 4.5g every 8 hours 3
- Ceftriaxone 1-2g daily plus metronidazole 500 mg IV every 8 hours 3
- Meropenem 1g IV every 8 hours for critically ill or suspected resistant organisms 3
Bite Wounds
Animal bites:
- Amoxicillin-clavulanate 875-125 mg twice daily for 5-7 days 3
- Doxycycline 100 mg twice daily plus metronidazole 500 mg four times daily for penicillin allergy 3
Human bites:
- Amoxicillin-clavulanate 875-125 mg twice daily 3
- Moxifloxacin 400 mg daily or ceftriaxone 1g daily for severe infections 3
Immunocompromised Patients
Aggressive and prolonged antimicrobial therapy with early combination treatment is essential for immunodeficient patients. 3
Prophylaxis regimens for bacterial respiratory infections:
- Amoxicillin 500-1000 mg daily or twice daily 3
- TMP-SMX 160 mg daily or twice daily 3
- Azithromycin 500 mg weekly or 250 mg every other day 3
Critical warning: Standard antibiotic doses and durations are often inadequate in immunocompromised hosts; consider prolonged courses and combination therapy 3
Key Principles
- Duration matters: Shorter courses (5-7 days) are equally effective as longer courses for most common infections while reducing resistance and adverse effects 3, 4
- Avoid fluoroquinolones as first-line except for specific indications due to resistance concerns and adverse effect profile 3, 2
- Culture-directed therapy: Obtain cultures for complicated infections and adjust antibiotics based on susceptibility results 2
- Clinical stability criteria: Switch from IV to oral therapy when fever resolves, patient tolerates oral intake, and clinical improvement is evident 3